Renfang Mao

Oncology · 2013

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 27 citations into it
• Immunology — 21 citations into it
• Cancer Research — 20 citations into it

Whom Renfang Mao trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Karin

Papers from Renfang Mao's perspective

Ordered by how strongly the researchers Renfang Mao trusts endorse each paper. Same corpus, a different order for every researcher.

1. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells (Nature Medicine)
2. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. (Journal of Clinical Investigation)
3. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. (Cell)
4. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. (Cancer Cell)
5. Cancer-related inflammation (Nature)
6. Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells (Journal of Experimental Medicine)
7. NF-κB functions as a tumour promoter in inflammation-associated cancer (Nature)
8. The STATs of cancer — new molecular targets come of age (Nature Reviews. Cancer)
9. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens (Nature Medicine)
10. Interleukin-6: from basic science to medicine--40 years in immunology. (Annual Review of Immunology)

Their papers

• NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer (2013) — 700 citations